Umbilical cord clamping and skin-to-skin contact in deliveries from women positive for SARS-CoV-2: a prospective observational study
Umbilical cord clamping and skin-to-skin contact in deliveries from women positive for SARS-CoV-2: a prospective observational study
复制标题
DOI:
10.1111/1471-0528.16597
复制
发表时间:
2020-11-30
影响因子:
5.8
通讯作者:
Martinez Perez, O.
中科院分区:
文献类型:
--
作者:
Mejia Jimenez, I;Salvador Lopez, R.;Martinez Perez, O.
Objective To demonstrate that delayed cord clamping (DCC) is safe in mothers with confirmed SARS-CoV-2 infection.Design, setting and participants Prospective observational study involving epidemiological information from 403 pregnant women with SARS-CoV-2 between 1 March and 31 May 2020. Data were collected from 70 centres that participate in the Spanish Registry of COVID-19.Methods Patients' information was collected from their medical chart.Main outcomes and measures The rate of perinatal transmission of SARS-CoV-2 and development of the infection in neonates within 14 days postpartum.Results The early cord clamping (ECC) group consisted of 231 infants (57.3%) and the DCC group consisted of 172 infants (42.7%). Five positive newborns (1.7% of total tests performed) were identified with the nasopharyngeal PCR tests performed in the first 12 hours postpartum, two from the ECC group (1.7%) and three from the DCC group (3.6%). No significant differences between groups were found regarding neonatal tests for SARS-CoV-2. No confirmed cases of vertical transmission were detected. The percentage of mothers who made skin-to-skin contact within the first 24 hours after delivery was significantly higher in the DCC group (84.3% versus 45.9%). Breastfeeding in the immediate postpartum period was also significantly higher in the DCC group (77.3% versus 50.2%).Conclusions The results of our study show no differences in perinatal outcomes when performing ECC or DCC, and skin-to-skin contact, or breastfeeding.Tweetable abstract This study demonstrates that delayed cord clamping is safe in mothers with confirmed SARS-CoV-2 infection.